Featured Clinical Trial


Cancer in your esophagus, the tube that runs from your throat to your stomach, is one of the most frequently reported and a leading cause of cancer deaths around the world. Most cases are reported in developing countries. Early esophageal cancer typically causes no symptoms. However, its chemical markers are present in the earliest stage. A new device being tested in England takes advantage of that to allow early detection of esophageal and other types of cancer. Faith Lapidus reports.
Originally published at -

Survivor Stories

30 Radiation, 4 Chemo Treatments, 4 Surgeries. She is a cancer survivor, a photographer, cinematographer, speaker, educator, owner and CEO of Unashamed Imaging.

Meet and greet in honor of Clare Minnerath, cancer survivor. All proceeds went to the Gloria Gemma Foundation.


Featured Hospital


The fight against childhood cancer got a big bump at Helen DeVos Children's Hospital, which welcomed a check for $1 million Monday. (Jan. 14, 2019)

Featured Articles

Neuroblastoma is a relatively common childhood cancer. About one in 10,000 children born will be affected. A diagnosis of neuroblastoma is frightening and trying to understand what comes next is often frustrating and confusing for the family. Children with neuroblastoma will often have surgery to assess and remove the main tumor. Lymph nodes will be tested from near the tumor, and from other parts of the body if it seems the cancer has spread. Other information and test results will be combined with the tumor's stage to assign the neuroblastoma patient to a risk group. Risk group classification helps determine the recommended treatment and helps to predict whether the tumor is likely to come back after treatment.
Standardized criteria for placing patients in risk groups have been, and continue to be, developed to ensure that everyone is "speaking the same language" about neuroblastoma. In the United States, many doctors have been using the Children's Oncology Group (COG) Risk Group Assignment. The International Neuroblastoma Risk Group classification is becoming more

Tamoxifen is a drug used to treat advanced breast cancer and, in some cases, to prevent breast cancer in women with exceptionally high risk. Tamoxifen is a hormone antagonist, specifically binding to estrogen receptors and preventing cancer cells receiving the hormone that they require to grow and multiply.

Until recently, tamoxifen has been taken orally. Oral tamoxifen, while effective, is also plagued by a long list of side effects. The trouble is that, by taking the drug orally, all of the estrogen receptors in the body are affected rather than just those in the breasts, where the drug is needed. New research and new drug design have shown promise in reducing the side effects of tamoxifen while maintaining its efficacy. The results have been achieved with a gel form of the drug that is rubbed directly on to the breasts.

Topical Tamoxifen

The whole point of tamoxifen is to keep cancer cells from arising in breast tissue. To that end, the drug is really only of use in breast tissue. When taken orally, tamoxifen reaches the breasts in adequate doses

Featured Oncologist


Published on Aug 31, 2016

Phillip Martin Pierorazio, M.D. is an expert in treating urinary-tract malignancies—including kidney, bladder, prostate, testis, adrenal, penile and urethral cancers. He performs both open and minimally invasive surgeries. These include laparoscopic and robotic surgeries of the kidney, bladder, prostate, and retroperitoneal lymph node dissection for testicular cancer. He has a special interest in kidney cancer and performs such specialized procedures as partial nephrectomy for early-stage disease and high-risk surgeries for advanced urological cancers. He is the Director of the Division of Testicular Cancer and works with a number of testicular cancer advocacy groups around the country. Learn more about Dr. Pierorazio at:

Featured Products

The cover of the book "Nowhere Hair" shows a mom, little girl and dog playing on the beach. But there's something a little different about this mom: she doesn't have hair. This is the premise of "Nowhere Hair," a book written by Sue Glader to help parents explain cancer and chemotherapy treatments to children.

The book's narrator is a little girl whose mom is missing her hair. The little girl goes looking for her mother's hair all throughout her home. Her mother explains to her daughter that medicine made it fall out, and that it was nothing the little girl did to make that happen. Written in rhyme, the book covers many sensitive topics, such as cancer, wearing hats and scarves to cover a head and that some people look different, which is okay.

The organization selected the book for children ages 3 to 12 to help kids understand a parent's diagnosis. The Moonbeam Children's Book Awards also selected the book as its 2011 Gold Medal Winner in the "Health" category.

Author Sue Glader is a breast cancer survivor who lives in Marin County, California. She Life can change on a dime. It's what you do after you pick up the pieces that counts.

You Can Help

Team Xplore's picture

This interview was taped in April 2013, prior to the "Fashion For Jandie" benefiting event.

Jandie's story is long and heart breaking about her battle with stage four Mesenchymal Chondrosarcoma; But to summarize it- in the beginning, she was rejected by doctors when complaining about her excruciating leg pain, being accused of only wanting pain killers. They eventually sent her to physical therapy creating pressure and strain, thus causing her leg to break, all the while not knowing she had bone cancer. Since the doctors pushed her away instead of trying to figure out the issue, her cancer then spread to her lungs until it was finally found.

On February 9th, 2015, she found out the cancer was now in her brain, as well. February 11th she had emergency brain surgery and they were only able to remove 80% of the tumor, as the remaining 20% was up against a blood vessel that affects her motor skills.

Jandie has also had tremendous stress with her finances in supporting her battle against cancer. Her medical bills are deep in collections, and every month she has